Hanane Mansouri

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies

Yahya Ashraf, Hanane Mansouri, Valérie Laurent‐Matha et al. · Journal for ImmunoTherapy of Cancer · 2019 · 92 citations · Full text

Medicine, Cancer Biology, Oncology +17

<scp>SPARC</scp> in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activity

Lindsay B. Alcaraz, Aude Mallavialle, Caroline Mollévi et al. · International Journal of Cancer · 2022 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +17

Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival

Hanane Mansouri, Lindsay B. Alcaraz, Caroline Mollévi et al. · Cancers · 2020 · 24 citations · Full text

Medicine, Cancer Biology, Oncology +17

Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer

Timothée David, Aude Mallavialle, Julien Faget et al. · British Journal of Pharmacology · 2023 · 13 citations · Full text

Life Sciences, Immunology, Oncology +15

A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer

Pénélope Desroys du Roure, Laurie Lajoie, Aude Mallavialle et al. · Journal for ImmunoTherapy of Cancer · 2024 · 13 citations · Full text

Life Sciences, Immunology, Oncology +17